CorMedix Inc. Reports on Shareholder Vote Matters
Ticker: CRMD · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1410098
| Field | Detail |
|---|---|
| Company | Cormedix Inc. (CRMD) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: CRMD
TL;DR
CRMD held a shareholder vote on 6/24, details to follow.
AI Summary
CorMedix Inc. filed an 8-K on June 25, 2025, reporting on matters submitted to a vote of its security holders on June 24, 2025. The filing does not detail the specific proposals voted on or their outcomes, but it is a standard disclosure for such events.
Why It Matters
This filing indicates that CorMedix Inc. held a vote of its security holders, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — This is a routine filing for a shareholder vote and does not contain new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- CorMedix Inc. (company) — Registrant
- June 24, 2025 (date) — Date of earliest event reported
- June 25, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 001-34673 (identifier) — Commission File Number
- 300 Connell Drive, Suite 4200 Berkeley Heights, NJ 07922 (address) — Principal executive offices
- (908) 517-9500 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of CorMedix Inc.'s security holders on June 24, 2025?
The filing does not specify the exact proposals voted on, only that matters were submitted to a vote.
When was this Form 8-K filed with the SEC?
This Form 8-K was filed on June 25, 2025.
What is the principal executive office address for CorMedix Inc.?
The principal executive offices are located at 300 Connell Drive, Suite 4200, Berkeley Heights, NJ 07922.
What is CorMedix Inc.'s telephone number?
CorMedix Inc.'s telephone number is (908) 517-9500.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding CorMedix Inc. (CRMD).